Image

Determinants of Metabolic Control in Children With Type 1 Diabetes Mellitus

Determinants of Metabolic Control in Children With Type 1 Diabetes Mellitus

Recruiting
6-21 years
All
Phase N/A

Powered by AI

Overview

A good metabolic control of type 1 diabetes mellitus (T1DM) is crucial to avoid long-term complications associated with the disease. Although recent evidences suggest that a good metabolic control of T1DM is partly independent of management intensity and could be anticipated since onset, factors that influence glycated haemoglobin (HbA1c) patterns remain poorly understood and are likely to be genetic.

While significant progress has been made in understanding of the genetic contribution to T1DM onset, very few studies have evaluated the role of genetic factors on T1DM metabolic control.

This study aims to create a comprehensive database of genetic and phenotypic data in a cohort of children and young adults with T1DM and to evaluate genetic and environmental factors that might predict trajectories in glycemic control

Eligibility

Inclusion Criteria

Cases
  • age between 6 and 21 years;
  • patients suffering from type 1 diabetes
Controls
  • age between 6 and 21 years;
  • patients for whom a venous sampling is planned

Exclusion criteria

Cases
  • patients for whom it is not possible to collect information on the clinical history, starting from the onset of diabetes
  • patients with other types of diabetes mellitus (type 2, monogenic diabetes, diabetes related to cystic fibrosis...)
  • patients incapable of expressing valid informed consent or whose parents are incapable of expressing valid informed consent.
Controls
  • subjects with type 1 and 2 diabetes
  • obese subjects and those with a family history of diabetes and obesity or other metabolic disorders
  • subjects with HbA1c >6%
  • patients incapable of expressing valid informed consent or whose parents are incapable of expressing valid informed consent.

Study details
    Diabetes Mellitus
    Type 1

NCT06317454

IRCCS Burlo Garofolo

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.